TTS 2024 - October 21-23 Virtual Program
Member Access to TTS 2024 Recordings
We are excited to announce that all TTS members now have exclusive access to the recordings from the TTS 2024 Congress. Whether you were able to attend in person or not, this is a fantastic opportunity to revisit key presentations, explore groundbreaking research, and deepen your understanding of the latest advances in transplantation science. These recordings are available for your ongoing professional development and to help you stay current with the most important trends and innovations in our field. We hope you find them valuable as a resource for your continued learning and engagement with the global transplantation community.
TTS 2024 Congress Recording Sponsored by:
WTC 2025 - Deadline was October 11 however we are accepting submissions over the weekend!!
Needs Assessment Survey & Call For Program Sessions
WTC 2025 Needs Your Opinion
We are seeking your valuable input to improve the upcoming 2025 World Transplant Congress. We would greatly appreciate your participation in a short (8min) Needs Assessment Survey. You can access the survey by clicking on the button “Survey Link” below. The deadline to complete was October 11, 2024, at 11:29 pm (EST) however we are accepting submissions over the weekend.
Please note that you are not required to complete the entire survey. Feel free to provide input on the sections that are the most relevant to you. Your responses will be incredibly helpful, even if you choose to answer just a few questions.
Thank you for your time and insights!
The WTC 2025 Organizing CommitteeWTC 2025 - Call for Sessions
On behalf of the American Society of Transplantation, the American Society of Transplant Surgeons, and The Transplantation Society, we are delighted to invite you to submit your ideas for program sessions for the World Transplant Congress 2025 (WTC 2025), to be held from August 2-6, 2025, in San Francisco, California, USA.
We are looking for programs that will be interactive, include global themes, speakers, and moderators, and focus on cutting-edge topics that address transplantation and end organ failure.
Just Released - Transplantation Direct - October Issue
The October Transplantation Direct issue is ready for viewing. Many aspects of transplantation are covered in this issue including the area of organ donation where outcomes following changes in HTLV screening practice in the US are evaluated, and the influence of using procurement teams not affiliated with recipient centers on DCD liver transplant outcomes. We have an article on textbook outcomes in organ transplantation being proposed for quality benchmarking. Patients in need of a bioartificial pancreas are explored in another paper. In liver transplantation, a critical analysis has been done on recipients over 75 years old, and another article looks at performing liver transplants in patients with portopulmonary hypertension. A new GFR calculation is proposed to evaluate living donors in kidney transplantation, and the impact of induction therapy and high-risk viral discordance in the USA is determined in older kidney recipients. For our pediatric and heart experts, we have an article on using ddcfDNA measurements as a predictor in pediatric heart transplant recipients. In addition, for those interested in composite tissue transplantation, molecular signatures associated with acute rejection are explored. Please visit our Transplantation Direct website for all the details on these and other articles, all which are freely available to everyone by open access.
Table of Contents
Kidney Transplantation
- Performance of the New CKD-EPI Creatinine-and Cystatin C–based Glomerular Filtration Rate Estimation Equation in Living Kidney Donor Candidate
- Outcomes of Older Primary Kidney Transplant Recipients by Induction Agent and High-risk Viral Discordance Status in the United States
Liver Transplantation
- Beyond 75: Graft Allocation and Organ Utility Implications in Liver Transplantation
- Making Living-donor Liver Transplantation a Viable Option for Patients With Portopulmonary Hypertension
Heart Transplantation
Hand and Composite Tissue Allotransplantation
Pancreas and Islet Transplantation
Organ Donation and Procurement
- Deceased Organ Donor HTLV Screening Practices Postelimination of Universal Screening in the United States
- The Association Between the Origin of the Donation After Circulatory Death Liver Recovery Team and Graft Survival: A National Study
Clinical Method
Transplantation Journal Highlights
Transplantation and Transplantation Direct - Editors at TTS 2024 Istanbul Congress
Executive Editors, Carla Baan and Stefan G. Tullius; Editor-in-Chief, Jeremy R. Chapmans;
Social Media Editor, Macey L. Levan
Deputy Editor, Fadi Issa; Social Media Editor, Macey L. Levan; Executive Editors, Stefan G. Tullius and Edward K. Geissler; Associate Editor, Jennifer Li; Executive Editor, Carla C. Baan; Associate Editor, Xunrong Luo
Transplantation - Social Media Content
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation
The human microbiome is associated with human health and disease. Exogenous compounds, including pharmaceutical products, are also known to be affected by the microbiome, and this discovery has led to the field of pharmacomicobiomics. The microbiome can also alter drug pharmacokinetics and pharmacodynamics, possibly resulting in side effects, toxicities, and unanticipated disease response. Microbiome-mediated effects are referred to as drug–microbiome interactions (DMI).
Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation
Posttransplant lymphoproliferative disorders (PTLDs) are among the most common malignant complications after transplantation, leading to a drastic reduction in patient survival rates. The majority of PTLDs are tightly linked to Epstein-Barr virus (EBV+PTLDs) and are the result of an uncontrolled proliferation of EBV-infected cells. However, although EBV infections are a common finding in transplant recipients, most patients with high EBV loads will never develop EBV+PTLD.
Transplantation Direct - Social Media Content
Risk Stratification Before Living Donor Kidney Transplantation in Patients With Preformed Donor-specific Antibodies by Different Crossmatch Methods
Preformed donor-specific HLA antibodies (DSA) are a well-known risk factor in kidney transplantation. There is still considerable debate, however, about the optimal risk stratification among patients with preformed DSA. Additionally, data on the prognostic value of different crossmatch assays in DSA-positive patients are scarce.
Impact of Intrapatient Immunosuppression Variability in Liver Transplantation Outcomes: A Systematic Review and Meta-analysis
To investigate the impact of intrapatient variability (IPV) in the levels of immunosuppressant drugs on health outcomes after liver transplantation, a comprehensive systematic review and meta-analysis were conducted.
5th Summit on Stem Cell Derived Islets - Online Registration Closes October 22nd!
IPTA-VES - International Pediatric Transplant Association Virtual Education Symposium
ISODP Journal Watch - October 2024
ISN-TTS Sister Centers Program Application Deadline
The program is a joint partnership between the International Society of Nephrology (ISN) and The Transplantation Society (TTS) to help establish new kidney transplant centers and develop existing kidney transplant programs in emerging countries. Please note that the program is open to all ISN and TTS members.
Contact
Address
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada